Monthly Archives: September 2023

Survival for Patients With Blood Cancers May Depend on Social Factors

Health insurance — among other factors — can play a role in the survival of patients with blood cancer, recent research showed. Factors including insurance coverage, economic status and marital status can affect survival outcomes and health disparities for patients with blood cancers, according to findings presented at the 2023 Society of Hematologic Oncology (SOHO) […]

‘I could just see her blood pressure drop’: Son’s final moments with dying mum

Carmen Walker is remembered by her family as a warm and caring great-grandmother whose death after a procedure at Waikato Hospital in 2010 was devastating. Photo / Stuart Munro WARNING: This story details a medical event that resulted in a patient death and may be upsetting. It’s the sight of the blood pooling on the […]

Tony Hawk Painted 100 Skateboards With His Own Blood

You may think you know everything there is to know about skateboarding legend Tony Hawk, but the famous athlete has tons of cool stories you’ve probably never heard before. For Men’s Health, Hawk looked at some of the comments about him shared across social media, and gave pretty great stories about his career and even […]

How to create a cardio-oncology program

He said a co-directorship means both sides have “skin in the game” to make the cardio-oncology center successful. “And when you try to explain what cardio-oncology is all about to the oncologists, you need to tell them it is not about stopping chemotherapy; it is exactly the opposite. The idea we have as cardiologists is […]

COVID patients exhale up to 1,000 copies of virus per minute during first eight days of symptoms

“We developed this easy, cheap method and used it to collect over 300 breath samples from 44 patients over the course of their infections — multiple samples a day over multiple days,” Lane said. With this new device, investigators detected viral RNA in 100% of specimens collected from COVID-positive patients who were within 10 days […]

Fixed-Duration Data Foreshadow Earlier Use of Loncastuximab Tesirine in Relapsed/Refractory DLBCL

Blood Cancer © laszlo – stock.adobe.com Loncastuximab tesirine-lpyl (Zynlonta) plus rituximab (Rituxan; Lonca-R) demonstrated promising antitumor activity and consistent safety signals in patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to updated data from the phase 3 LOTIS-5 trial (NCT04384484) that were presented at the 2023 SOHO Annual Meeting.1 As of the data cutoff […]

Quizartinib Plus Induction Chemotherapy Provides Survival Benefit in FLT3 ITD–Mutated AML

Harry P. Erba, MD, PhD The addition of quizartinib (Vanflyta) to induction and consolidation chemotherapy, followed by single-agent quizartinib for up to 36 cycles, improved survival outcomes vs placebo in patients with FLT3 ITD–mutated, newly diagnosed acute myeloid leukemia (AML), according to a presentation given by Harry P. Erba, MD, PhD at the 2023 SOHO Annual Meeting. […]

Mount Sinai researchers identify the structure of a special red blood cell transporter

Researchers at the Icahn School of Medicine at Mount Sinai have identified the structure of a special transporter found in red blood cells and how it interacts with drugs. Details on the findings, which were reported in the September 7 issue of Nature Structural & Molecular Biology [DOI: 10.1038/s41594-023-01085-6], could lead to the development of […]